Insiders / Heyman Richard A.

Heyman Richard A.

CIK 1584759personinsider

Companies

2

First seen

Jan 6, 2026

Last activity

Feb 19, 2026

Companies

Company	Role	Shares held	Peak held	Trades	Latest
Oric Pharmaceuticals, Inc. · ORIC	Director	254,872	213,072	3	—
Enliven Therapeutics, Inc. · ELVN	Director	22,647	29,392	7	—

All securities held

4 positions · latest reported per filing

Company	Security	Shares	As of
Enliven Therapeutics, Inc.	Common Stock	22,647	Feb 17, 2026
Enliven Therapeutics, Inc.	Stock Option (right to buy)Derivative	19,234	Feb 12, 2026
Oric Pharmaceuticals, Inc.	Common Stock	254,872	Jan 16, 2026
Oric Pharmaceuticals, Inc.	Stock Option (right to buy)Derivative	40,000	Jan 2, 2026

Activity

InsidersInstitutions

This person's insider trades (Form 4), across every company.

Date	Action	Company	Value	Shares Δ	Position after	Impact
Jan 8, 2026	Sell	ELVN Enliven Therapeutics, Inc. Common Stock	$200.7K	-8K -21.43%	29,392 0.04% of shares	medium
Jan 9, 2026	Sell	ELVN Enliven Therapeutics, Inc. Common Stock	$107.1K	-4K -14.58%	25,107 0.03% of shares	medium
Jan 16, 2026	Sell	ORIC Oric Pharmaceuticals, Inc. Common Stock	$42.0K	-4K -7.73%	41,800 0.04% of shares	low
Jan 8, 2026	Sell	ELVN Enliven Therapeutics, Inc. Common Stock	$40.5K	-2K -5.96%	25,545 0.03% of shares	low
Jan 16, 2026	Sell	ORIC Oric Pharmaceuticals, Inc. Common Stock	$38.4K	-3K -1.48%	213,072 0.21% of shares	low
Feb 17, 2026	Sell	ELVN Enliven Therapeutics, Inc. Common Stock	$32.2K	-1K -5.15%	22,647 0.03% of shares	low
Jan 20, 2026	Sell	ELVN Enliven Therapeutics, Inc. Common Stock	$19.4K	-718 -2.92%	23,877 0.03% of shares	low
Jan 20, 2026	Sell	ELVN Enliven Therapeutics, Inc. Common Stock	$13.5K	-512 -2.04%	24,595 0.03% of shares	low
Jan 2, 2026	Grant	ORIC Oric Pharmaceuticals, Inc. Stock Option (right to buy)	—	+40K	40,000 0.04% of shares	low
Feb 12, 2026	Grant	ELVN Enliven Therapeutics, Inc. Stock Option (right to buy)	—	+19K	19,234 0.03% of shares	low